We proudly support the scientific community by providing investigators with funding opportunities for research that aligns with our therapeutic areas of interest.


By providing granting opportunities to investigators, Context Therapeutics is firmly committed to forwarding scientific research that increases our understanding of scientific and clinical aspects of disease and therapeutics, improving medical care, promoting better healthcare delivery, and providing benefits to patients.

Investigator Sponsored Trial (IST) refers to an unsolicited clinical trial proposed and sponsored by an Investigator at a hospital, medical center, medical school, private foundation, private practice, group practice, or government-sponsored research network. ISTs are unique, novel, and scientifically valid research evaluating unmet medical needs.


Name *

All ISTs must meet the following requirements in order to receive funding or support from Context:

  • Investigators are qualified to conduct the study and comply with applicable regulatory obligations;

  • The amount of funding represents the fair market value of the work performed in the study;

  • The research is not duplicative or a pretense to promote Context products.

Research priorities, information regarding the application process, and approval criteria for ISTs are communicated by Context Medical Affairs personnel to healthcare providers. Upon receiving an unsolicited request, Medical Affairs personnel may provide advice on draft proposals, however, the proposal must be completed by healthcare providers.

Investigators are also responsible for all trial‑related medical decisions, monitoring the study, and ensuring that adequate medical care is provided for Adverse Events (AE). While Context reserves the right to review any manuscripts or presentations resulting from an IST prior to submission, investigators will determine how the results of the IST are publicized.

Context will only provide funding and support in accordance with an approved proposal and fully executed contract. Any Investigator who wishes to request additional support for an ongoing IST or seek a modification of the executed contract must seek prior written approval from the IST Review Committee. Context may withdraw support if an Investigator fails to comply with applicable Legal and/or regulatory obligations or provided false information in the proposal, or as otherwise specified in the contract. Context may not increase or decrease funding or support amounts depending on whether or not the IST results reflect favorably upon Context products or any competitor products.